Adenosine secreted from myeloid cells is shown to modulate TGF-β signaling in proximal fibroblasts by reducing phosphorylation of Smad2/3 and to affect ECM deposition and therefore influence the tumor microenvironment of mammary carcinoma (Vasiukov et al., 2020). The gene discussed is TGFB1; the disease is breast carcinoma.